BioCentury
ARTICLE | Financial News

Celldex proposes follow-on

December 4, 2013 1:17 AM UTC

Celldex Therapeutics Inc. (NASDAQ:CLDX) proposed to sell 6.5 million shares in a follow-on underwritten by Jefferies and Leerink. If sold at Celldex's close of $27.14 on Tuesday, before the company proposed the offering, Celldex would raise $176.4 million. Celldex was off $0.04 on Tuesday. ...